Title:
POLYCYCLIC POLY(ADP-RIBOSE) POLYMERASE SELECTIVE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2024/093956
Kind Code:
A1
Abstract:
The present invention relates to the technical field of medicines, in particular to a polycyclic poly(ADP-ribose) polymerase (PARP) selective inhibitor compound as represented by general formula (I), a pharmaceutically acceptable salt thereof or a stereoisomer thereof, a pharmaceutical composition containing the compound, the pharmaceutically acceptable salt thereof or the stereoisomer thereof, a method for preparing the compound, the pharmaceutically acceptable salt thereof or the stereoisomer thereof, and a use of the compound, the pharmaceutically acceptable salt thereof or the stereoisomer thereof.
Inventors:
LIU BIN (CN)
CHEN BO (CN)
CHEN BO (CN)
Application Number:
PCT/CN2023/128071
Publication Date:
May 10, 2024
Filing Date:
October 31, 2023
Export Citation:
Assignee:
SHANDONG XUANZHU PHARMA CO LTD (CN)
International Classes:
C07D519/00; A61K31/444; A61K31/4545; A61P35/00; C07D401/14; C07D471/04
Domestic Patent References:
| WO2023122140A1 | 2023-06-29 | |||
| WO2022222921A1 | 2022-10-27 | |||
| WO2011014681A1 | 2011-02-03 |
Foreign References:
| CN115232154A | 2022-10-25 |
Download PDF: